Recruit complementary expertise and disclose interests. The following are interview candidates selected from public professional profiles and speaking records—not a confirmed panel.
| Proposed expert | Verified basis for approaching them | Suggested interview focus |
|---|---|---|
| Jesse C. Dresser, Esq. | Frier Levitt partner and head of its Pharmacy Practice Group; his published practice includes compounding, mail-order and dispensing physician practices. (frierlevitt.com) | Route eligibility, pharmacy contracts, state requirements and commercial incentives |
| Tenille Davis, PharmD | Chief Advocacy Officer, Alliance for Pharmacy Compounding. Treat her contribution as an explicitly disclosed compounding-sector perspective. (a4pc.org) | Patient-specific compounding, operational documentation and practical objections to the buyer framework |
| Robert F. Kushner, MD | Northwestern lists him as Professor Emeritus in Medicine, Endocrinology, Metabolism and Molecular Medicine, with substantial obesity-treatment research. (feinberg.northwestern.edu) | Clinical independence, patient suitability and safe treatment transitions |
| Michael Ganio, PharmD | ASHP identifies him as senior director of pharmacy practice and quality; he testified on pharmaceutical supply-chain issues in January 2026. (news.ashp.org) | Quality diligence, medication safety and supply-chain responsibilities |
| Erin R. Fox, PharmD | Her 2026 healthcare-leadership conference profile identifies her as University of Utah Health’s associate chief pharmacy officer for shared services, with purchasing and drug-shortage responsibilities. (ache2026.eventscribe.net) | Allocation, continuity, purchasing data and operational contingency planning |
| Adam J. Fein, PhD | President of Drug Channels Institute, whose stated work covers pharmaceutical economics, distribution and reimbursement. (drugchannelsinstitute.com) | Patient cash prices versus acquisition costs, expenditure control and comparison methodology |
| Raechele “Rae” McMahan | Prescryptive’s senior vice president for payer solutions, according to her published conference profile, with experience across pharmacy-benefit and manufacturer-contracting functions. (informaconnect.com) | Manufacturer-linked access, price visibility and pharmacy workflow integration |
Before recording, request disclosure of relevant employment, consulting, research funding, ownership, litigation representation and supplier relationships. Also interview the proposed dispensing partner’s pharmacist-in-charge and an existing provider customer, but keep their operational evidence separate from independent expert interpretation.
Ask every participant: Which part of our framing is wrong, what evidence would change your view, and what remains outside your expertise?
Explore the table row by row
A working view of the research
Jesse C. Dresser, Esq.
- Verified basis for approaching them
- Frier Levitt partner and head of its Pharmacy Practice Group; his published practice includes compounding, mail-order and dispensing physician practices. (frierlevitt.com)
- Suggested interview focus
- Route eligibility, pharmacy contracts, state requirements and commercial incentives
Sources cited on this page
- frierlevitt.com · Source 1 ↗https://www.frierlevitt.com/attorney/jesse-c-dresser/
- a4pc.org · Source 2 ↗https://a4pc.org/staff?utm_source=openai
- feinberg.northwestern.edu · Source 3 ↗https://www.feinberg.northwestern.edu/sites/diabetes/members/profile.html?xid=11686&utm_source=openai
- news.ashp.org · Source 4 ↗https://news.ashp.org/News/ashp-news/2026/01/29/ashp-expert-on-drug-shortages-testifies-before-senate-committee?utm_source=openai
- ache2026.eventscribe.net · Source 5 ↗https://ache2026.eventscribe.net/fsPopup.asp?PresenterID=2271052&efp=TFdYTktWT0cyNTg3OQ&mode=presenterinfo&rnd=0.3316944&utm_source=openai
- drugchannelsinstitute.com · Source 6 ↗https://drugchannelsinstitute.com/about/leadership/?utm_source=openai
- informaconnect.com · Source 7 ↗https://informaconnect.com/pbm-contracting/speakers/rae-mcmahan/?utm_source=openai